Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Neelima Gupta, Sukanya Shyamasundar, Radhika Patnala, Aparna Karthikeyan, Thiruma V. Arumugam, Eng-Ang Ling & S. Thameem Dheen. (2018) Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies. Expert Opinion on Therapeutic Targets 22:9, pages 765-781.
Read now
Read now
Jaume Folch, Dmitry Petrov, Miren Ettcheto, Ignacio Pedrós, Sonia Abad, Carlos Beas-Zarate, Alberto Lazarowski, Miguel Marin, Jordi Olloquequi, Carme Auladell & Antoni Camins. (2015) Masitinib for the treatment of mild to moderate Alzheimer’s disease. Expert Review of Neurotherapeutics 15:6, pages 587-596.
Read now
Read now
Articles from other publishers (64)
Junhua Li, Lin Wang, Qinhua Zeng, Jing He, Qing Tang, Kejian Wang & Guiqiong He. (2023)
MKP
‐1 regulates the inflammatory activation of microglia against Alzheimer's disease
. CNS Neuroscience & Therapeutics.
Crossref
Crossref
Mohammed Dheyaa Marsool Marsool, Priyadarshi Prajjwal, Yeruva Bheemeswara Reddy, Ali Dheyaa Marsool Marsool, Justin Riley Lam & Varsha Nandwana. (2023) Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases. Disease-a-Month 69:5, pages 101547.
Crossref
Crossref
Shikha Kushwah, Neha Shree Maurya, Sandeep Kushwaha, Luciana Scotti, Aakash Chawade & Ashutosh Mani. (2023) Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine
System from the Modern Viewpoint. Current Neuropharmacology 21:4, pages 764-776.
Crossref
Crossref
Yi-Ge Wu, Li-Juan Song, Li-Jun Yin, Jun-Jun Yin, Qing Wang, Jie-Zhong Yu, Bao-Guo Xiao & Cun-Gen Ma. (2023) The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease. Neural Regeneration Research 18:5, pages 947.
Crossref
Crossref
Yong Mo, Weilin Xu, Kaijing Fu, Hainan Chen, Jing Wen, Qianrong Huang, Fangzhou Guo, Ligen Mo & Jun Yan. (2022) The dual function of microglial polarization and its treatment targets in ischemic stroke. Frontiers in Neurology 13.
Crossref
Crossref
Houmin Lin, Steven Grant Dixon, Wei Hu, Eric D. Hamlett, Junfei Jin, Adviye Ergul & Gavin Y. Wang. (2022) p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia. Molecular Neurobiology 59:9, pages 5284-5298.
Crossref
Crossref
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio & Manuele Gori. (2022) Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Frontiers in Neuroscience 16.
Crossref
Crossref
Rohit Malik, Sunishtha Kalra, Saurabh Bhatia, Ahmed Al Harrasi, Govind Singh, Syam Mohan, Hafiz A. Makeen, Mohammed Albratty, Abdulkarim Meraya, Bojlul Bahar & Murtaza M. Tambuwala. (2022) Overview of therapeutic targets in management of dementia. Biomedicine & Pharmacotherapy 152, pages 113168.
Crossref
Crossref
Arga Setyo Adji, Jordan Steven Widjaja, Vira Aulia Kusuma Wardani, Alvian Habib Muhammad, Fitri Handajani, Hendy Bhaskara Perdana Putra & Firman Suryadi Rahman. (2022) A Review of CRISPR Cas9 for Alzheimer’s Disease: Treatment Strategies and Could target APOE e4, APP, and PSEN-1 Gene using CRISPR cas9 Prevent the Patient from Alzheimer’s Disease?. Open Access Macedonian Journal of Medical Sciences 10:F, pages 745-757.
Crossref
Crossref
Ling‐Jing Zhang, Hong‐Su Zhou, Shi‐Ya Wang, Yi‐Huan Guan, Chao Zhang & De‐Rong Fang. (2022) Changes in microglia during drug treatment of stroke. Ibrain 8:2, pages 227-240.
Crossref
Crossref
Alexander Grotemeyer, Rhonda Leah McFleder, Jingjing Wu, Jörg Wischhusen & Chi Wang Ip. (2022) Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification. Frontiers in Immunology 13.
Crossref
Crossref
Hsin-Ping Liu, Yueh-Hsiung Kuo, Jack Cheng, Li-Zhong Chang, Meng-Shiun Chang, Li-Wen Su, Tsai-Ni Chuang & Wei-Yong Lin. (2021) Ergosta-7,9(11),22-trien-3β-ol Rescues AD Deficits by Modulating Microglia Activation but Not Oxidative Stress. Molecules 26:17, pages 5338.
Crossref
Crossref
Mohammad Bagherniya, Hamed Khedmatgozar, Omid Fakheran, Suowen Xu, Thomas P. Johnston & Amirhossein Sahebkar. (2021)
Medicinal plants and bioactive natural products as inhibitors of
NLRP3
inflammasome
. Phytotherapy Research 35:9, pages 4804-4833.
Crossref
Crossref
Yi-Jun Wang, Alina Monteagudo, Matthew A. Downey, Philip G. Ashton-Rickardt & David R. Elmaleh. (2021) Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3). Scientific Reports 11:1.
Crossref
Crossref
Timothy M. Shoup, Ana Griciuc, Marc D. Normandin, Luisa Quinti, Lindsay V. Walsh, Maeva Dhaynaut, Sung-Hyun Moon, Nicolas J. Guehl, Pedro Brugarolas, David R. Elmaleh, Georges El Fakhri & Rudolph E. Tanzi. (2021) Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer’s Disease. Journal of Alzheimer's Disease 80:2, pages 775-786.
Crossref
Crossref
Rakesh K. Singh. (2020) Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches. Current Neuropharmacology 18:9, pages 868-882.
Crossref
Crossref
Rakesh Kumar Singh. (2020) Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer’s disease. Neurological Sciences 41:8, pages 2081-2093.
Crossref
Crossref
Elham Hadipour, Akram Taleghani, Nilufar Tayarani‐Najaran & Zahra Tayarani‐Najaran. (2020) Biological effects of red beetroot and betalains: A review. Phytotherapy Research 34:8, pages 1847-1867.
Crossref
Crossref
Katherine E. Olson, R. Lee Mosley & Howard E. Gendelman. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
335
370
.
Xin Zhong, Mingyan Liu, Weifan Yao, Ke Du, Miao He, Xin Jin, Linchi Jiao, Guowei Ma, Binbin Wei & Minjie Wei. (2019) Epigallocatechin‐3‐Gallate Attenuates Microglial Inflammation and Neurotoxicity by Suppressing the Activation of Canonical and Noncanonical Inflammasome via TLR4/NF‐κB Pathway. Molecular Nutrition & Food Research 63:21.
Crossref
Crossref
David R. Elmaleh, Martin R. Farlow, Peter S. Conti, Ronald G. Tompkins, Ljiljana Kundakovic & Rudolph E. Tanzi. (2019) Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions. Journal of Alzheimer's Disease 71:3, pages 715-732.
Crossref
Crossref
Emel Koseoglu. (2019) New treatment modalities in Alzheimer's disease. World Journal of Clinical Cases 7:14, pages 1764-1774.
Crossref
Crossref
Howard Friel. (2019) Biopharmaceutical Monotargeting versus ‘Universal Targeting’ of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds. Journal of Alzheimer's Disease Reports 3:1, pages 219-232.
Crossref
Crossref
Yu‐Wen Cheng, Chun‐Cheng Chang, Ti‐Sheng Chang, Hsin‐Hua Li, Hui‐Chih Hung, Guang‐Yaw Liu & Chih‐Li Lin. (2018) Aβ stimulates microglial activation through antizyme‐dependent downregulation of ornithine decarboxylase. Journal of Cellular Physiology 234:6, pages 9733-9745.
Crossref
Crossref
Liqing Song, Yuanwei Yan, Mark Marzano & Yan Li. (2019) Studying Heterotypic Cell–Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration. Cells 8:4, pages 299.
Crossref
Crossref
Liansheng Zhong, Xue Jiang, Zhihui Zhu, Haiyan Qin, Michael B. Dinkins, Ji‐Na Kong, Silvia Leanhart, Rebecca Wang, Ahmed Elsherbini, Erhard Bieberich, Yujie Zhao & Guanghu Wang. (2018) Lipid transporter Spns2 promotes microglia pro‐inflammatory activation in response to amyloid‐beta peptide. Glia 67:3, pages 498-511.
Crossref
Crossref
Baban S. Thawkar & Ginpreet Kaur. (2019) Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease. Journal of Neuroimmunology 326, pages 62-74.
Crossref
Crossref
Syed Obaidur Rahman, Rakesh Kumar Singh, Salman Hussain, Mohd. Akhtar & Abul Kalam Najmi. (2019) A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease. European Journal of Pharmacology 842, pages 208-220.
Crossref
Crossref
Nooshin Heshmati-Fakhr, Fattah Sotoodehnejadnematalahi, Niloufar Yousefi, Mohammad Sayyah, Sayed Masoud Hosseini & Hamid Gholami Pourbadie. (2018) Triggering microglia through toll-like receptor 2 pathway induced interferon β expression in cell and animal model of Alzheimer’s disease. NeuroReport 29:17, pages 1456-1462.
Crossref
Crossref
Xiaoguang Du, Xinyi Wang & Meiyu Geng. (2018) Alzheimer’s disease hypothesis and related therapies. Translational Neurodegeneration 7:1.
Crossref
Crossref
Tomomi Kiyota, Jatin Machhi, Yaman Lu, Bhagyalaxmi Dyavarshetty, Maryam Nemati, Gang Zhang, R. Lee Mosley, Harris A. Gelbard & Howard E. Gendelman. (2018) URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Jie Feng, Jing‐Xue Wang, Ye‐Hong Du, Ying Liu, Wei Zhang, Jing‐Fei Chen, Yuan‐Jie Liu, Min Zheng, Ke‐Jian Wang & Gui‐Qiong He. (2018)
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing
NLRP
3 inflammasome activation in
APP
/
PS
1 transgenic mice
. CNS Neuroscience & Therapeutics 24:12, pages 1207-1218.
Crossref
Crossref
Joseph Rogers. (2018) Principles for central nervous system inflammation research: A call for a consortium approach. Alzheimer's & Dementia 14:11, pages 1553-1559.
Crossref
Crossref
Kazuyuki Takata, Takahide Amamiya, Hiroaki Mizoguchi, Shohei Kawanishi, Eriko Kuroda, Risa Kitamura, Aina Ito, Yuki Saito, Manami Tawa, Tomofumi Nagasawa, Haruka Okamoto, Yuko Sugino, Shigehiko Takegami, Tatsuya Kitade, Yuki Toda, William R. Kem, Yoshihisa Kitamura, Shun Shimohama & Eishi Ashihara. (2018) Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease. Neurobiology of Aging 62, pages 197-209.
Crossref
Crossref
Ronit Shapira, Beka Solomon, Shai Efrati, Dan Frenkel & Uri Ashery. (2018) Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiology of Aging 62, pages 105-119.
Crossref
Crossref
Duraisamy Kempuraj, Govindhasamy P. Selvakumar, Ramasamy Thangavel, Mohammad E. Ahmed, Smita Zaheer, Sudhanshu P. Raikwar, Shankar S. Iyer, Sachin M. Bhagavan, Swathi Beladakere-Ramaswamy & Asgar Zaheer. (2017) Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis. Frontiers in Neuroscience 11.
Crossref
Crossref
Anne K. Braczynski, Jörg B. Schulz & Jan-Philipp Bach. (2017) Vaccination strategies in tauopathies and synucleinopathies. Journal of Neurochemistry 143:5, pages 467-488.
Crossref
Crossref
Yun Zhang & Mao-lin He. (2017) Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice. Brain Research 1677, pages 86-92.
Crossref
Crossref
Marta Sochocka, Breno Satler Diniz & Jerzy Leszek. (2016) Inflammatory Response in the CNS: Friend or Foe?. Molecular Neurobiology 54:10, pages 8071-8089.
Crossref
Crossref
Xiaolei Shi, Xiaoying Cai, Wei Di, Jie Li, Xiaotian Xu, Aiwu Zhang, Weiwei Qi, Zhiming Zhou & Yannan Fang. (2016) MFG-E8 Selectively Inhibited Aβ-Induced Microglial M1 Polarization via NF-κB and PI3K-Akt Pathways. Molecular Neurobiology 54:10, pages 7777-7788.
Crossref
Crossref
Stefano Thellung, Elena Gatta, Francesca Pellistri, Valentina Villa, Alessandro Corsaro, Mario Nizzari, Mauro Robello & Tullio Florio. (2017) Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90–231 Neurotoxic Effects in Cerebellar Granule Neurons. Neurotoxicity Research 32:3, pages 381-397.
Crossref
Crossref
Milan Fiala, Gijs Kooij, Karen Wagner, Bruce Hammock & Matteo Pellegrini. (2017) Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids. The FASEB Journal 31:8, pages 3229-3239.
Crossref
Crossref
Janani Singaravelu, Lian Zhao, Robert N. Fariss, T. Michael Nork & Wai T. Wong. (2017) Microglia in the primate macula: specializations in microglial distribution and morphology with retinal position and with aging. Brain Structure and Function 222:6, pages 2759-2771.
Crossref
Crossref
Yirong Ding, Ji Zhang & Rui Wang. (2017) Inhibition of tissue transglutaminase attenuates lipopolysaccharide-induced inflammation in glial cells through AKT/mTOR signal pathway. Biomedicine & Pharmacotherapy 89, pages 1310-1319.
Crossref
Crossref
Tim Karl, Brett Garner & David Cheng. (2017) The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease. Behavioural Pharmacology 28:2 and 3, pages 142-160.
Crossref
Crossref
Glyn Chidlow, John P.M. Wood, Jim Manavis, John Finnie & Robert J. Casson. (2017) Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 56:2, pages 655-675.
Crossref
Crossref
Yan-mei Zhang, Wei Wu, Wei Ma, Fang Wang & Jun Yuan. (2017) Effect of glycosides of Cistanche on the expression of mitochondrial precursor protein and keratin type II cytoskeletal 6A in a rat model of vascular dementia. Neural Regeneration Research 12:7, pages 1152.
Crossref
Crossref
Chen Liang, Jian-Ping Yuan, Tao Ding, Lv Yan, Lu Ling, Xin-Fu Zhou & Yue-Qin Zeng. (2017)
Neuroprotective Effect of
Fagopyrum dibotrys
Extract against Alzheimer’s Disease
. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-9.
Crossref
Crossref
Sam Famenini, Elizabeth A. Rigali, Henry M. Olivera‐Perez, Johnny Dang, Michael To Chang, Ramesh Halder, Rammohan V. Rao, Matteo Pellegrini, Verna Porter, Dale Bredesen & Milan Fiala. (2016) Increased intermediate M1‐M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω‐3 supplementation. The FASEB Journal 31:1, pages 148-160.
Crossref
Crossref
Weiguo Dong, Christine M. Embury, Yaman Lu, Sarah M. Whitmire, Bhagyalaxmi Dyavarshetty, Harris A. Gelbard, Howard E. Gendelman & Tomomi Kiyota. (2016) The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. Journal of Neuroinflammation 13:1.
Crossref
Crossref
Ryan C. McCarthy, Dah-Yuu Lu, Ahmed Alkhateeb, Andrew M. Gardeck, Chih-Hao Lee & Marianne Wessling-Resnick. (2016) Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta. Journal of Neuroinflammation 13:1.
Crossref
Crossref
Aijuan Yan, Tingting Zhang, Xiao Yang, Jiaxiang Shao, Ningzhen Fu, Fanxia Shen, Yi Fu & Weiliang Xia. (2016) Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury. Scientific Reports 6:1.
Crossref
Crossref
Fan Zhang, Yi-An Lin, Sujatha Kannan & Rangaramanujam M. Kannan. (2016) Targeting specific cells in the brain with nanomedicines for CNS therapies. Journal of Controlled Release 240, pages 212-226.
Crossref
Crossref
Hongxia Xing, Shuangxi Guo, Yi Zhang, Zhiyong Zheng & Haoliang Wang. (2016) Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia. Molecular Medicine Reports 14:2, pages 1357-1364.
Crossref
Crossref
Ester Aso & Isidro Ferrer. (2016) CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease. Frontiers in Neuroscience 10.
Crossref
Crossref
Anna Chiarini, Ubaldo Armato, Daisong Liu & Ilaria Dal Prà. (2016) Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease. Frontiers in Physiology 7.
Crossref
Crossref
Joe Herbert & Paul J. Lucassen. (2016) Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?. Frontiers in Neuroendocrinology 41, pages 153-171.
Crossref
Crossref
Xiao-Ling Luo, Si-Yu Liu, Li-Jun Wang, Qiu-Yan Zhang, Peng Xu, Li-Long Pan & Jin-Feng Hu. (2016) A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia. European Journal of Pharmacology 774, pages 135-143.
Crossref
Crossref
Ji Jia, Jie Peng, Zhaoju Li, Youping Wu, Qunlin Wu, Weifeng Tu & Mingchun Wu. (2016)
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to
β
Amyloid via Protein Kinase C
. Mediators of Inflammation 2016, pages 1-10.
Crossref
Crossref
YAN WANG, JIZONG LIN, QING-ZHUANG CHEN, NING ZHU, DE-QI JIANG, MING-XING LI & YONG WANG. (2015) Overexpression of mitochondrial Hsp75 protects neural stem cells against microglia-derived soluble factor-induced neurotoxicity by regulating mitochondrial permeability transition pore opening in vitro. International Journal of Molecular Medicine 36:6, pages 1487-1496.
Crossref
Crossref
Christine M. SandiegoJean-Dominique GallezotBrian PittmanNabeel NabulsiKeunpoong LimShu-Fei LinDavid MatuskeyJae-Yun LeeKevin C. O’ConnorYiyun HuangRichard E. CarsonJonas Hannestad & Kelly P. Cosgrove. (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proceedings of the National Academy of Sciences 112:40, pages 12468-12473.
Crossref
Crossref
Mak Adam Daulatzai. (2015) “Boomerang Neuropathology” of Late-Onset Alzheimer’s Disease is Shrouded in Harmful “BDDS”: Breathing, Diet, Drinking, and Sleep During Aging. Neurotoxicity Research 28:1, pages 55-93.
Crossref
Crossref
Anil Kumar, Dinesh K. Dhull & Pooja S. Mishra. (2015) Therapeutic potential of mGluR5 targeting in Alzheimer's disease. Frontiers in Neuroscience 9.
Crossref
Crossref
Zhen Yu, Ling Tang, Lifen Chen, Jifang Li, Wanfu Wu & Changlin Hu. (2015) Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-κB and MAPKs Signaling Pathway. Neurochemical Research 40:6, pages 1095-1101.
Crossref
Crossref